MOSCOW, Aug. 11 (Sputnik) - The vaccine, known as “Sputnik-V” was developed by the Gamaleya Research Institute, and its mass production has already begun at AFK Sistema's Binnopharm pharmaceutical factory. The total output of the drug is expected to reach 500 million doses in the first 12 months.

Russian Health Minister Mikhail Murashko Wednesday announced that the first batch of the long-awaited coronavirus vaccine will be produced and ready for use in 2 weeks.

"Today, quality control tests are underway. Within two weeks, the first batch of the drug will be released and will be delivered for [vaccination of] medics in health risk groups".

He stressed the vaccination will be voluntary for everybody, including medics, adding that a special tracing app is now in development which will allow Russian citizens to confirm the state of their health. The app will also monitor possible adverse effects of the drug for those who took the vaccine.

Murashko said that the vaccine will be primarily used to meet demand within Russia, bit didn't rule out exporting the drug. He also noted that criticism of the vaccine abroad is baseless and is caused by the fear of fair competition.

The Russian authorities previously said that the Gamaleya vaccine's two-stage plan could provide immunity against the coronavirus for up to two years.